Dramatic erythroid response to low‐dose thalidomide in two patients with transfusion independent thalassemia and severe post‐transfusional alloimmune hemolysis
暂无分享,去创建一个
E. Angelucci | C. Fozza | F. Dore | P. Dessalvi | A. D. Di Tucci | C. Targhetta | S. Pardini | Domenica Barbara Giannico
[1] S. Philipsen,et al. Transfusion-independent β(0)-thalassemia after bone marrow transplantation failure: proposed involvement of high parental HbF and an epigenetic mechanism. , 2014, American journal of blood research.
[2] M. Soleimani,et al. The Role of Epigenetics in the Induction of Fetal Hemoglobin: A Combination Therapy Approach , 2014, International journal of hematology-oncology and stem cell research.
[3] J. Scandura,et al. Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia , 2013, Leukemia & lymphoma.
[4] M. Shahjahani,et al. Evaluation of Novel Fetal Hemoglobin Inducer Drugs in Treatment of β-Hemoglobinopathy Disorders , 2013, International journal of hematology-oncology and stem cell research.
[5] Rongrong Liu,et al. Analysis of Gγ-158(C→T) polymorphism in hemoglobin E/β-thalassemia major in Southern China , 2010, Journal of hematology & oncology.
[6] J. Dipersio,et al. Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] G. Masera,et al. Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy. , 2010, Blood transfusion = Trasfusione del sangue.
[8] J. L. Delgado-Lamas,et al. Thalidomide therapy in a patient with thalassemia major. , 2008, Blood cells, molecules & diseases.
[9] D. Verhelle,et al. Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cells. , 2008, Journal of Clinical Investigation.